# FDA Inspection 1085327 - Samsung Bioepis Co., Ltd. - February 15, 2019

Source: https://www.keypedia.com/records/fda_inspections/samsung-bioepis-co-ltd/e13e32a8-0e2e-415d-addf-5974d87453c5
Source feed: FDA_Inspections

> FDA Inspection 1085327 for Samsung Bioepis Co., Ltd. on February 15, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1085327
- Company Name: Samsung Bioepis Co., Ltd.
- Inspection Date: 2019-02-15
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1255085 - 2024-11-22](https://www.keypedia.com/records/fda_inspections/samsung-bioepis-co-ltd/23accb9f-3a49-4ade-9f19-567e7e2c9ccc)
- [FDA Inspection 1255085 - 2024-11-22](https://www.keypedia.com/records/fda_inspections/samsung-bioepis-co-ltd/0faf7c9a-5c91-4a0d-ac4b-15d0806fbab4)
- [FDA Inspection 1217751 - 2023-09-15](https://www.keypedia.com/records/fda_inspections/samsung-bioepis-co-ltd/96b8ce4b-6861-4cb4-9759-9c3a866832b6)
- [FDA Inspection 988922 - 2016-08-19](https://www.keypedia.com/records/fda_inspections/samsung-bioepis-co-ltd/7bf919e3-1434-4a86-8cd8-0bf0214d815a)

Company: https://www.keypedia.com/companies/samsung-bioepis-co-ltd/6473332d-84de-441c-82fe-4034d7383d5e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c